StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Benitec Biopharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Benitec Biopharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$16.52M. For fiscal 2026 it was -$16.52M. The highest annual figure on record is $4.79M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$16.52M–
FY2025Jun 30, 2025-$23.59M–
FY2024Jun 30, 2024-$19.40M–
FY2023Jun 30, 2023-$18.01M–
FY2022Jun 30, 2022-$15.90M–
FY2021Jun 30, 2021-$12.83M–
FY2020Jun 30, 2020-$7.54M-257.3%
FY2019Jun 30, 2019$4.79M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$4.94M–
Q3 FY2026CQ1 2026Mar 31, 2026-$4.45M–
Q2 FY2026CQ4 2025Dec 31, 2025-$3.78M–
Q1 FY2026CQ3 2025Sep 30, 2025-$3.35M–
Q4 FY2025CQ2 2025Jun 30, 2025-$8.21M–
Q3 FY2025CQ1 2025Mar 31, 2025-$3.09M–
Q2 FY2025CQ4 2024Dec 31, 2024-$7.70M–
Q1 FY2025CQ3 2024Sep 30, 2024-$4.59M–
Q4 FY2024CQ2 2024Jun 30, 2024-$3.29M–
Q3 FY2024CQ1 2024Mar 31, 2024-$6.17M–
Q2 FY2024CQ4 2023Dec 31, 2023-$5.37M–
Q1 FY2024CQ3 2023Sep 30, 2023-$4.58M–
Q4 FY2023CQ2 2023Jun 30, 2023-$4.10M–
Q3 FY2023CQ1 2023Mar 31, 2023-$4.03M–
Q2 FY2023CQ4 2022Dec 31, 2022-$5.84M–
Q1 FY2023CQ3 2022Sep 30, 2022-$4.05M–
Q4 FY2022CQ2 2022Jun 30, 2022-$4.86M–
Q3 FY2022CQ1 2022Mar 31, 2022-$3.42M–
Q2 FY2022CQ4 2021Dec 31, 2021-$3.34M–
Q1 FY2022CQ3 2021Sep 30, 2021-$4.28M–
Q4 FY2021CQ2 2021Jun 30, 2021-$5.16M–
Q3 FY2021CQ1 2021Mar 31, 2021-$1.99M–
Q2 FY2021CQ4 2020Dec 31, 2020-$3.33M–
Q1 FY2021CQ3 2020Sep 30, 2020-$2.36M–
Q4 FY2020CQ2 2020Jun 30, 2020-$3.15M–
Q3 FY2020CQ1 2020Mar 31, 2020-$769.00K–
Q2 FY2020CQ4 2019Dec 31, 2019-$3.08M–
Q1 FY2020CQ3 2019Sep 30, 2019-$545.00K–

More Benitec Biopharma figures

See a number that looks wrong?